OGEN logo

Oragenics (OGEN) Cash From Investing

Annual CFI

-$936.30 K
-$820.80 K-710.65%

December 31, 2023

Summary

Performance

1-Year Change

-710.65%

3-Year Change

-100%

5-Year Change

-650.84%

15-Year Change

-100%

OGEN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.22%
OGEN annual cash flow from investing activities is higher than 44.22% of companies in Healthcare sector

High & Low

All-time High

$1.68 M
OGEN annual cash flow from investing activities is currently -155.90% below its historical high of $1.68 million

3-Year Low

-$936.30 K
OGEN annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OGEN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
OGEN next annual earnings announcement is scheduled for May 15, 2025

OtherOGENcash flowmetrics:

Annual CFF

$283.90 K
OGEN annual cash flow from financing activities is $283.90 thousand

Annual CFO

-$7.29 M
OGEN annual cash flow from operations is -$7.29 million

Annual FCF

-$8.29 M
OGEN annual free cash flow is -$8.29 million

Annual CAPEX

-
OGEN annual capital expenditures value is unknown

Quarterly CFI

$0.00
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

OGEN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.16%
OGEN quarterly cash flow from investing activities is higher than 68.16% of companies in Healthcare sector

High & Low

All-time High

$1.25 M
OGEN quarterly cash flow from investing activities is currently -100.00% below its historical high of $1.25 million

3-Year Low

-$1.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OGEN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
OGEN next earnings announcement is scheduled for May 15, 2025

OtherOGENcash flowmetrics:

Quarterly CFF

$3.77 M
OGEN quarterly cash flow from financing activities is $3.77 million

Quarterly CFO

-$1.97 M
OGEN quarterly cash flow from operations is -$1.97 million

Quarterly FCF

-$1.97 M
OGEN quarterly free cash flow is -$1.97 million

Quarterly CAPEX

-
OGEN quarterly capital expenditures value is unknown

TTM CFI

-$1.00 M
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-6.8%

3-Year Change

-6.8%

5-Year Change

-6.8%

OGEN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.92%
OGEN TTM cash flow from investing activities is higher than 44.92% of companies in Healthcare sector

High & Low

All-time High

$1.68 M
OGEN TTM cash flow from investing activities is currently -159.70% below its historical high of $1.68 million

3-Year Low

-$1.00 M
OGEN TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OGEN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
OGEN next earnings announcement is scheduled for May 15, 2025

OtherOGENcash flowmetrics:

TTM CFF

$6.06 M
OGEN TTM cash flow from financing activities is $6.06 million

TTM CFO

-$7.68 M
OGEN TTM cash flow from operations is -$7.68 million

TTM FCF

-$7.68 M
OGEN TTM free cash flow is -$7.68 million

TTM CAPEX

-
OGEN TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

OGEN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-710.6%+100.0%-6.8%
3 y3 years-100.0%+100.0%-6.8%
5 y5 years-650.8%+100.0%-6.8%

OGEN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2032.8%at low-100.0%+100.0%-1758.4%at low
5 y5-year<-9999.0%at low-100.0%+100.0%-1758.4%at low
alltimeall time-155.9%at low-100.0%+100.0%-159.7%+23.6%

Oragenics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
-$1.00 M(+6.8%)
Dec 2023
-$936.30 K(+710.6%)
-$1.00 M(-1669.9%)
-$936.30 K(-1652.7%)
Sep 2023
-
$63.70 K(-1973.5%)
$60.30 K(-152.3%)
Dec 2022
-$115.50 K(+163.1%)
-$3400.00(-90.8%)
-$115.40 K(-12.4%)
Sep 2022
-
-$37.00 K(<-9900.0%)
-$131.80 K(+10.8%)
Jun 2022
-
$0.00(-100.0%)
-$118.90 K(0.0%)
Mar 2022
-
-$75.00 K(+278.8%)
-$118.90 K(+170.8%)
Dec 2021
-$43.90 K(<-9900.0%)
-$19.80 K(-17.8%)
-$43.90 K(+82.2%)
Sep 2021
-
-$24.10 K(<-9900.0%)
-$24.10 K(<-9900.0%)
Jun 2021
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2021
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2020
-
$0.00(-100.0%)
-$13.90 K(-45.1%)
Dec 2019
-$25.20 K(-79.8%)
-$13.90 K(<-9900.0%)
-$25.30 K(-66.7%)
Sep 2019
-
$0.00(-100.0%)
-$75.90 K(-44.2%)
Jun 2019
-
-$11.40 K(-82.3%)
-$136.10 K(+9.1%)
Dec 2018
-$124.70 K(<-9900.0%)
-$64.50 K(+7.1%)
-$124.70 K(+107.1%)
Sep 2018
-
-$60.20 K(<-9900.0%)
-$60.20 K(<-9900.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2017
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2017
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2016
$1.68 M(-1755.1%)
$0.00(-100.0%)
$1.68 M(0.0%)
Sep 2016
-
$425.00 K(-66.0%)
$1.68 M(+34.8%)
Jun 2016
-
$1.25 M(>+9900.0%)
$1.24 M(-1328.0%)
Dec 2015
-$101.20 K(-8.2%)
$0.00(-100.0%)
-$101.20 K(-47.2%)
Sep 2015
-
-$7300.00(-66.4%)
-$191.70 K(+3.3%)
Jun 2015
-
-$21.70 K(-69.9%)
-$185.60 K(+13.5%)
Mar 2015
-
-$72.20 K(-20.2%)
-$163.50 K(+48.4%)
Dec 2014
-$110.20 K(+486.2%)
-$90.50 K(+7441.7%)
-$110.20 K(+427.3%)
Sep 2014
-
-$1200.00(-400.0%)
-$20.90 K(-32.6%)
Jun 2014
-
$400.00(-102.1%)
-$31.00 K(-18.0%)
Mar 2014
-
-$18.90 K(+1475.0%)
-$37.80 K(+100.0%)
Dec 2013
-$18.80 K(+69.4%)
-$1200.00(-89.4%)
-$18.90 K(-34.4%)
Sep 2013
-
-$11.30 K(+76.6%)
-$28.80 K(+64.6%)
Jun 2013
-
-$6400.00(<-9900.0%)
-$17.50 K(+57.7%)
Mar 2013
-
$0.00(-100.0%)
-$11.10 K(0.0%)
Dec 2012
-$11.10 K
-$11.10 K(<-9900.0%)
-$11.10 K(<-9900.0%)
DateAnnualQuarterlyTTM
Sep 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Jun 2011
-
$0.00(-100.0%)
-$81.90 K(-7.0%)
Dec 2010
-$88.10 K(-385.1%)
$91.30 K(-152.7%)
-$88.10 K(-47.4%)
Sep 2010
-
-$173.20 K(<-9900.0%)
-$167.40 K(-2986.2%)
Jun 2010
-
$0.00(-100.0%)
$5800.00(-82.8%)
Mar 2010
-
-$6200.00(-151.7%)
$33.80 K(+9.4%)
Dec 2009
$30.90 K(-335.9%)
$12.00 K(>+9900.0%)
$30.90 K(+106.0%)
Sep 2009
-
$0.00(-100.0%)
$15.00 K(-484.6%)
Jun 2009
-
$28.00 K(-407.7%)
-$3900.00(-92.1%)
Mar 2009
-
-$9100.00(+133.3%)
-$49.40 K(+277.1%)
Dec 2008
-$13.10 K(+32.3%)
-$3900.00(-79.4%)
-$13.10 K(+42.4%)
Sep 2008
-
-$18.90 K(+8.0%)
-$9200.00(-255.9%)
Jun 2008
-
-$17.50 K(-164.3%)
$5900.00(-74.8%)
Mar 2008
-
$27.20 K(>+9900.0%)
$23.40 K(-336.4%)
Dec 2007
-$9900.00(+41.4%)
$0.00(-100.0%)
-$9900.00(-47.9%)
Sep 2007
-
-$3800.00(<-9900.0%)
-$19.00 K(+14.5%)
Jun 2007
-
$0.00(-100.0%)
-$16.60 K(0.0%)
Mar 2007
-
-$6100.00(-33.0%)
-$16.60 K(+137.1%)
Dec 2006
-$7000.00(-98.9%)
-$9100.00(+550.0%)
-$7000.00(-433.3%)
Sep 2006
-
-$1400.00(<-9900.0%)
$2100.00(-223.5%)
Jun 2006
-
$0.00(-100.0%)
-$1700.00(-98.3%)
Mar 2006
-
$3500.00(>+9900.0%)
-$101.30 K(-84.8%)
Dec 2005
-$666.30 K(-3.5%)
$0.00(-100.0%)
-$666.30 K(-38.1%)
Sep 2005
-
-$5200.00(-94.8%)
-$1.08 M(-17.8%)
Jun 2005
-
-$99.60 K(-82.3%)
-$1.31 M(+6.6%)
Mar 2005
-
-$561.50 K(+37.1%)
-$1.23 M(+77.8%)
Dec 2004
-$690.50 K(+1272.8%)
-$409.60 K(+72.1%)
-$690.60 K(+137.8%)
Sep 2004
-
-$238.00 K(+1166.0%)
-$290.40 K(+330.2%)
Jun 2004
-
-$18.80 K(-22.3%)
-$67.50 K(+32.9%)
Mar 2004
-
-$24.20 K(+157.4%)
-$50.80 K(+1.2%)
Dec 2003
-$50.30 K
-$9400.00(-37.7%)
-$50.20 K(+23.0%)
Sep 2003
-
-$15.10 K(+619.0%)
-$40.80 K(+58.8%)
Jun 2003
-
-$2100.00(-91.1%)
-$25.70 K(+8.9%)
Mar 2003
-
-$23.60 K
-$23.60 K

FAQ

  • What is Oragenics annual cash flow from investing activities?
  • What is the all time high annual CFI for Oragenics?
  • What is Oragenics annual CFI year-on-year change?
  • What is Oragenics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Oragenics?
  • What is Oragenics quarterly CFI year-on-year change?
  • What is Oragenics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Oragenics?
  • What is Oragenics TTM CFI year-on-year change?

What is Oragenics annual cash flow from investing activities?

The current annual CFI of OGEN is -$936.30 K

What is the all time high annual CFI for Oragenics?

Oragenics all-time high annual cash flow from investing activities is $1.68 M

What is Oragenics annual CFI year-on-year change?

Over the past year, OGEN annual cash flow from investing activities has changed by -$820.80 K (-710.65%)

What is Oragenics quarterly cash flow from investing activities?

The current quarterly CFI of OGEN is $0.00

What is the all time high quarterly CFI for Oragenics?

Oragenics all-time high quarterly cash flow from investing activities is $1.25 M

What is Oragenics quarterly CFI year-on-year change?

Over the past year, OGEN quarterly cash flow from investing activities has changed by +$1.00 M (+100.00%)

What is Oragenics TTM cash flow from investing activities?

The current TTM CFI of OGEN is -$1.00 M

What is the all time high TTM CFI for Oragenics?

Oragenics all-time high TTM cash flow from investing activities is $1.68 M

What is Oragenics TTM CFI year-on-year change?

Over the past year, OGEN TTM cash flow from investing activities has changed by -$63.70 K (-6.80%)